SCHEMBL29633807

SCHEMBL29633807

COc1ccc(CCC(C(=O)O)N(C)C(=O)OCC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP5 Q01469 2/20 0.40
TAS2R14 Q9NYV8 1/20 0.36
CACNA1G O43497 1/20 0.35
CACNA1H O95180 1/20 0.35
CACNA1I Q9P0X4 1/20 0.35
MDM2 Q00987 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
FABP7 O15540 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
PKM P14618 1/20 0.34
ACACB O00763 1/20 0.34
PPARG P37231 1/20 0.34
PPARA Q07869 1/20 0.34
OXTR P30559 1/20 0.33
MDM4 O15151 1/20 0.33
TP53 P04637 1/20 0.33
NAMPT P43490 1/20 0.33
EPHX2 P34913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25357875 1.00 FABP5 (0.40) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL25357871 1.00 FABP5 (0.40) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL30054744 0.91 FABP5 (0.41) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL25355198 0.91 FABP5 (0.41) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL29633739 0.91 FABP5 (0.41) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL25182963 0.91 FABP5 (0.41) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL25183125 0.91 FABP5 (0.41) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL29633829 0.89 FABP5 (0.36) FABP5TAS2R14CACNA1GCACNA1HCACNA1I
SCHEMBL29633696 0.89 FABP5 (0.38) FABP5MDM2KMT2AFABP7PPARG
SCHEMBL31369914 0.85 MDM2 (0.43) FABP5MDM2KMT2AFABP7NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-11-14 US disclosed
US-12071396-B2 Method for preparing aromatic amino acid derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-08-27 US disclosed
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2022-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240376044-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885CACNA1G 4114/4885
US-20220144762-A1 METHOD FOR PREPARING AROMATIC AMINO ACID DERIVATIVE DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885CACNA1G 4114/4885
US-12071396-B2 Method for preparing aromatic amino acid derivative DDC, AADAT, TYR FABP5 608/4885TAS2R14 3521/4885CACNA1G 4114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.